Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 1/20 | 0.55 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.55 |
| ▸ | F2 | P00734 | 2/20 | 0.54 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.54 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.54 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.54 |
| ▸ | EDNRA | P25101 | 6/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | GBA1 | P04062 | 2/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13911551 | 1.00 | HDAC4 (0.55) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL29936015 | 1.00 | HDAC4 (0.55) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL29462219 | 1.00 | HDAC4 (0.55) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL9163130 | 0.88 | HDAC4 (0.58) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL14110615 | 0.88 | HDAC4 (0.48) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL14110750 | 0.85 | HDAC4 (0.55) | HDAC4HDAC10HDAC6HDAC5F2 | |
| SCHEMBL13651429 | 0.85 | HDAC4 (0.64) | HDAC4HDAC10HDAC6HDAC5GBA1 | |
| SCHEMBL29358078 | 0.85 | HDAC4 (0.64) | HDAC4HDAC10HDAC6HDAC5GBA1 | |
| SCHEMBL597355 | 0.85 | HDAC4 (0.64) | HDAC4HDAC10HDAC6HDAC5GBA1 | |
| SCHEMBL18612351 | 0.82 | EDNRA (0.59) | HDAC4HDAC10HDAC6HDAC5F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116601297-A | Modified helicase and application thereof | 北京齐碳科技有限公司 | 2023-08-15 | — | — | CN | claimed |
| US-20230212535-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-07-06 | — | — | US | claimed |
| EP-4198125-A2 | PIF1-LIKE HELICASE AND USE THEREOF | Qitan Technology Ltd., Beijing (CN) | 2023-06-21 | — | — | EP | claimed |
| EP-4063382-A9 | PIF1-LIKE HELICASE AND APPLICATION THEREOF | Qitan Technology Ltd., Beijing (CN) | 2022-11-16 | — | — | EP | claimed |
| EP-4063382-A1 | PIF1-LIKE HELICASE AND APPLICATION THEREOF | Qitan Technology Ltd., Beijing (CN) | 2022-09-28 | — | — | EP | claimed |
| US-20220290223-A1 | PIF1-LIKE HELICASE AND USE THEREOF | Qitan Technology Ltd. (CN) | 2022-09-15 | — | — | US | claimed |
| CN-113930406-A | Pif1-like helicase and application thereof | 北京齐碳科技有限公司 | 2022-01-14 | — | — | CN | claimed |
| US-20210009971-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2021-01-14 | — | — | US | claimed |
| EP-3575410-A2 | MODIFIED ENZYMES | Oxford Nanopore Technologies Limited (GB) | 2019-12-04 | — | — | EP | claimed |
| US-20180037874-A9 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2018-02-08 | — | — | US | claimed |
| US-20160257942-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2016-09-08 | — | — | US | claimed |
| EP-3058088-A2 | MODIFIED ENZYMES | Oxford Nanopore Technologies Limited (GB) | 2016-08-24 | — | — | EP | claimed |
| CN-105899678-A | Modified enzymes | 牛津纳米孔技术公司 | 2016-08-24 | — | — | CN | claimed |
| US-20150191709-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2015-07-09 | — | — | US | claimed |
| US-9073973-B2 | Dye conjugates of template-fixed peptidomimetics | POLYPHOR LTD. (CH) | 2015-07-07 | — | — | US | claimed |
| EP-2875128-A1 | MODIFIED HELICASES | Oxford Nanopore Technologies Limited (GB) | 2015-05-27 | — | — | EP | claimed |
| WO-2015055981-A2 | MODIFIED ENZYMES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2015-04-23 | — | — | WO | claimed |
| WO-2014013260-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2014-01-23 | — | — | WO | claimed |
| EP-1879911-B1 | DYE CONJUGATES OF TEMPLATE-FIXED PEPTIDOMIMETICS | POLYPHOR LTD (CH) | 2011-08-17 | — | — | EP | claimed |
| US-20260028379-A1 | MUTANT PORE | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2026-01-29 | — | — | US | disclosed |
| US-20250243472-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-07-31 | — | — | US | disclosed |
| US-12371458-B2 | Mutant pore | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-07-29 | — | — | US | disclosed |
| US-12258591-B2 | Modified helicases | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-03-25 | — | — | US | disclosed |
| US-12252717-B2 | Modified helicases | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-03-18 | — | — | US | disclosed |
| US-20240417704-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-12-19 | — | — | US | disclosed |
| US-20240368568-A1 | MODIFIED PRP43 HELICASE AND USE THEREOF | QITAN TECHNOLOGY LTD., CHENGDU (CN) | 2024-11-07 | — | — | US | disclosed |
| US-20240287485-A1 | MODIFIED ENZYMES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-08-29 | — | — | US | disclosed |
| US-20240271122-A1 | METHODS FOR CODON OPTIMIZATION AND USES THEREOF | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2024-08-15 | — | — | US | disclosed |
| US-20240254172-A1 | MUTANT PORE | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-08-01 | — | — | US | disclosed |
| EP-4397970-A2 | MUTANT PORE | Oxford Nanopore Technologies PLC (GB) | 2024-07-10 | — | — | EP | disclosed |
| CN-111534504-B | Method of ligating one or more polynucleotide binding proteins to a target polynucleotide | 牛津纳米孔科技公开有限公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-4122949-B1 | MUTANT PORE | OXFORD NANOPORE TECH PLC (GB) | 2024-06-05 | — | — | EP | disclosed |
| US-20240158735-A1 | METHODS AND COMPOSITIONS USING AN ENGINEERED RELEASE FACTOR | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2024-05-16 | — | — | US | disclosed |
| WO-2024086738-A2 | COMPOSITIONS AND METHODS OF USE FOR INTEINS | GRO BIOSCIENCES INC. (US) | 2024-04-25 | — | — | WO | disclosed |
| US-11965183-B2 | Modified enzymes | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-04-23 | — | — | US | disclosed |
| US-11939359-B2 | Mutant pore | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2024-03-26 | — | — | US | disclosed |
| US-20240026441-A1 | METHOD FOR ATTACHING ONE OR MORE POLYNUCLEOTIDE BINDING PROTEINS TO A TARGET POLYNUCLEOTIDE | Oxford Nanopre Technologies PLC (GB) | 2024-01-25 | — | — | US | disclosed |
| CN-116334030-B | Modified CfM HL4 helicase and application thereof | 深圳市梅丽纳米孔科技有限公司 | 2024-01-16 | — | — | CN | disclosed |
| EP-4299746-A1 | MODIFIED PRP43 HELICASE AND USE THEREOF | Qitan Technology Ltd., Chengdu (CN) | 2024-01-03 | — | — | EP | disclosed |
| US-20230374567-A1 | METHOD FOR MODIFYING A TEMPLATE DOUBLE STRANDED POLYNUCLEOTIDE | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-11-23 | — | — | US | disclosed |
| WO-2023198911-A2 | NOVEL MODIFIED PROTEIN PORES AND ENZYMES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-10-19 | — | — | WO | disclosed |
| US-11725235-B2 | Method for attaching one or more polynucleotide binding proteins to a target polynucleotide | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-08-15 | — | — | US | disclosed |
| US-20230227799-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-07-20 | — | — | US | disclosed |
| US-20230212535-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-07-06 | — | — | US | disclosed |
| CN-116334030-A | Modified CfM HL4 helicase and application thereof | 深圳市梅丽纳米孔科技有限公司 | 2023-06-27 | — | — | CN | disclosed |
| EP-4198125-A2 | PIF1-LIKE HELICASE AND USE THEREOF | Qitan Technology Ltd., Beijing (CN) | 2023-06-21 | — | — | EP | disclosed |
| US-11649480-B2 | Method for modifying a template double stranded polynucleotide | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2023-05-16 | — | — | US | disclosed |
| CN-115777019-A | Modified Prp43 helicases and uses thereof | 成都齐碳科技有限公司 | 2023-03-10 | — | — | CN | disclosed |
| EP-4122949-A1 | MUTANT PORE | Oxford Nanopore Technologies plc (GB) | 2023-01-25 | — | — | EP | disclosed |
| EP-4108679-A1 | MODIFIED ENZYMES | Oxford Nanopore Technologies plc (GB) | 2022-12-28 | — | — | EP | disclosed |
| US-11525125-B2 | Modified helicases | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2022-12-13 | — | — | US | disclosed |
| US-11525126-B2 | Modified helicases | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2022-12-13 | — | — | US | disclosed |
| EP-4063382-A9 | PIF1-LIKE HELICASE AND APPLICATION THEREOF | Qitan Technology Ltd., Beijing (CN) | 2022-11-16 | — | — | EP | disclosed |
| EP-4063382-A1 | PIF1-LIKE HELICASE AND APPLICATION THEREOF | Qitan Technology Ltd., Beijing (CN) | 2022-09-28 | — | — | EP | disclosed |
| US-20220290223-A1 | PIF1-LIKE HELICASE AND USE THEREOF | Qitan Technology Ltd. (CN) | 2022-09-15 | — | — | US | disclosed |
| EP-3440098-B1 | MUTANT PORE | OXFORD NANOPORE TECH PLC (GB) | 2022-07-27 | — | — | EP | disclosed |
| EP-3204406-B1 | MODIFIED ENZYMES | OXFORD NANOPORE TECH PLC (GB) | 2022-07-06 | — | — | EP | disclosed |
| CN-114599666-A | Pif1-like helicase and application thereof | 北京齐碳科技有限公司 | 2022-06-07 | — | — | CN | disclosed |
| US-20220162568-A1 | PORE | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2022-05-26 | — | — | US | disclosed |
| US-20220135956-A1 | MODIFIED ENZYMES | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2022-05-05 | — | — | US | disclosed |
| EP-3097210-B2 | METHOD FOR ATTACHING ONE OR MORE POLYNUCLEOTIDE BINDING PROTEINS TO A TARGET POLYNUCLEOTIDE | OXFORD NANOPORE TECH LTD (GB) | 2022-04-20 | — | — | EP | disclosed |
| CN-113930406-B | Pif1-like helicase and application thereof | 北京齐碳科技有限公司 | 2022-04-08 | — | — | CN | disclosed |
| US-20220064230-A1 | MUTANT PORE | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2022-03-03 | — | — | US | disclosed |
| CN-113930406-A | Pif1-like helicase and application thereof | 北京齐碳科技有限公司 | 2022-01-14 | — | — | CN | disclosed |
| US-11180741-B2 | Modified enzymes | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2021-11-23 | — | — | US | disclosed |
| US-20210123032-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2021-04-29 | — | — | US | disclosed |
| US-20210009971-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2021-01-14 | — | — | US | disclosed |
| EP-3741847-A1 | MODIFIED HELICASES | Oxford Nanopore Technologies Limited (GB) | 2020-11-25 | — | — | EP | disclosed |
| EP-3464615-B1 | METHOD | OXFORD NANOPORE TECH LTD (GB) | 2020-11-25 | — | — | EP | disclosed |
| US-10808231-B2 | Modified helicases | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2020-10-20 | — | — | US | disclosed |
| US-10724018-B2 | Modified helicases | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2020-07-28 | — | — | US | disclosed |
| US-20200087724-A1 | METHOD FOR ATTACHING ONE OR MORE POLYNUCLEOTIDE BINDING PROTEINS TO A TARGET POLYNUCLEOTIDE | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2020-03-19 | — | — | US | disclosed |
| US-10385389-B2 | Method for attaching one or more polynucleotide binding proteins to a target polynucleotide | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2019-08-20 | — | — | US | disclosed |
| US-20190202876-A1 | MUTANT PORE | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2019-07-04 | — | — | US | disclosed |
| US-20190194722-A1 | METHOD | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2019-06-27 | — | — | US | disclosed |
| EP-3440098-A1 | MUTANT PORE | Oxford Nanopore Technologies Limited (GB) | 2019-02-13 | — | — | EP | disclosed |
| CN-109219665-A | Method | 牛津纳米孔技术公司 | 2019-01-15 | — | — | CN | disclosed |
| CN-109071618-A | MUTANT PORE | 牛津纳米孔技术公司 | 2018-12-21 | — | — | CN | disclosed |
| EP-3097210-B1 | METHOD FOR ATTACHING ONE OR MORE POLYNUCLEOTIDE BINDING PROTEINS TO A TARGET POLYNUCLEOTIDE | OXFORD NANOPORE TECH LTD (GB) | 2018-11-14 | — | — | EP | disclosed |
| US-20180179500-A1 | MODIFIED ENZYMES | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2018-06-28 | — | — | US | disclosed |
| US-20180037874-A9 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2018-02-08 | — | — | US | disclosed |
| WO-2017174990-A1 | MUTANT PORE | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2017-10-12 | — | — | WO | disclosed |
| CN-107109380-A | Modified enzymes | 牛津纳米孔技术公司 | 2017-08-29 | — | — | CN | disclosed |
| EP-3204406-A2 | MODIFIED ENZYMES | Oxford Nanopore Technologies Limited (GB) | 2017-08-16 | — | — | EP | disclosed |
| US-20170107569-A1 | METHOD FOR ATTACHING ONE OR MORE POLYNUCLEOTIDE BINDING PROTEINS TO A TARGET POLYNUCLEOTIDE | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2017-04-20 | — | — | US | disclosed |
| EP-3097210-A1 | METHOD FOR ATTACHING ONE OR MORE POLYNUCLEOTIDE BINDING PROTEINS TO A TARGET POLYNUCLEOTIDE | Oxford Nanopore Technologies Limited (GB) | 2016-11-30 | — | — | EP | disclosed |
| US-20160257942-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LTD. (GB) | 2016-09-08 | — | — | US | disclosed |
| CN-105647824-A | In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris | 斯克利普斯研究院 | 2016-06-08 | — | — | CN | disclosed |
| WO-2016055777-A2 | MODIFIED ENZYMES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2016-04-14 | — | — | WO | disclosed |
| WO-2015183970-A1 | THERAPEUTIC COMPOSITIONS INCLUDING FLAVONOID AND USES THEREOF | STEALTH PEPTIDES INTERNATIONAL, INC. (MC) | 2015-12-03 | — | — | WO | disclosed |
| WO-2015183963-A2 | THERAPEUTIC COMPOSITIONS INCLUDING REDOX-ACTIVE PARABENZOQUINONES AND USES THEREOF | STEALTH PEPTIDES INTERNATIONAL, INC. (MC) | 2015-12-03 | — | — | WO | disclosed |
| CN-102307905-B | Chemical reactivity alpha-non-natural amino acid is utilized to produce carrier-peptide conjugate | THE SCRIPPS RESEARCH INSTITUTE (US) | 2015-11-25 | — | — | CN | disclosed |
| US-9102932-B2 | Orthogonal translation components for the in vivo incorporation of unnatural amino acids | THE SCRIPPS RESEARCH INSTITUTE (US) | 2015-08-11 | — | — | US | disclosed |
| WO-2015110813-A1 | METHOD FOR ATTACHING ONE OR MORE POLYNUCLEOTIDE BINDING PROTEINS TO A TARGET POLYNUCLEOTIDE | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2015-07-30 | — | — | WO | disclosed |
| US-20150191709-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2015-07-09 | — | — | US | disclosed |
| EP-2875128-A1 | MODIFIED HELICASES | Oxford Nanopore Technologies Limited (GB) | 2015-05-27 | — | — | EP | disclosed |
| WO-2014013260-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES LIMITED (GB) | 2014-01-23 | — | — | WO | disclosed |
| US-20130244245-A1 | Orthogonal Translation Components for the in Vivo Incorporation of Unnatural Amino Acids | THE SCRIPPS RESEARCH INSTITUTE (US) | 2013-09-19 | — | — | US | disclosed |
| US-8216804-B2 | pairs of orthogonal-tRNAs (O-tRNAs) and orthogonal aminoacyl-tRNA synthetases (O RSs) that do not interact with the host cell translation machinery | THE SCRIPPS RESEARCH INSTITUTE (US) | 2012-07-10 | — | — | US | disclosed |
| US-8183037-B2 | Expressing prokaryotic transfer RNA in yeast cells via vector transformation; disruuption of nonsense mediated messenger RNA decay | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2012-05-22 | — | — | US | disclosed |
| US-20120077224-A1 | UNNATURAL AMINO ACID INCORPORATION IN EUKARYOTIC CELLS | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2012-03-29 | — | — | US | disclosed |
| CN-102307905-A | Production of carrier-peptide conjugates using chemically reactive unnatural amino acids | SCRIPPS RESEARCH INST | 2012-01-04 | — | — | CN | disclosed |
| EP-2383340-A2 | Orthogonal translation components for the in vivo incorporation of unnatural amino acids | The Scripps Research Institute (US) | 2011-11-02 | — | — | EP | disclosed |
| EP-2380982-A1 | Orthogonal translation components for the in vivo incorporation of unnatural amino acids | The Scripps Research Institute (US) | 2011-10-26 | — | — | EP | disclosed |
| CN-101939410-A | In vivo unnatural amino acid expression in methylotrophic yeast Pichia pastoris | SCRIPPS RESEARCH INST | 2011-01-05 | — | — | CN | disclosed |
| WO-2010141851-A1 | IMPROVING UNNATURAL AMINO ACID INCORPORATION IN EUKARYOTIC CELLS | SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2010-12-09 | — | — | WO | disclosed |
| EP-2155890-A1 | METHODS OF GENETICALLY ENCODING UNNATURAL AMINO ACIDS IN EUKARYOTIC CELLS USING ORTHOGONAL TRNA/SYNTHETASE PAIRS | The Salk Institute for Biological Studies (US) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008127900-A1 | METHODS OF GENETICALLY ENCODING UNNATURAL AMINO ACIDS IN EUKARYOTIC CELLS USING ORTHOGONAL TRNA/SYNTHETASE PAIRS | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2008-10-23 | — | — | WO | disclosed |
| US-20080254540-A1 | METHODS OF GENETICALLY ENCODING UNNATURAL AMINO ACIDS IN EUKARYOTIC CELLS USING ORTHOGONAL tRNA/SYNTHETASE PAIRS | THE SALK INSTITUTE OFR BIOLOGICAL STUDIES | 2008-10-16 | — | — | US | disclosed |
| US-20080233611-A1 | Orthogonal Translation Components for the in Vivo Incorporation of Unnatural Amino Acids | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-09-25 | — | — | US | disclosed |
| US-20080233611-A1 | Orthogonal Translation Components for the in Vivo Incorporation of Unnatural Amino Acids | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-09-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11525126-B2 | Modified helicases | DDX21, DDX5, DDX17 | HDAC4 2288/4885HDAC10 2655/4885HDAC6 1819/4885 |
| US-20240417704-A1 | MODIFIED HELICASES | DDX21, DDX5, DDX17 | HDAC4 2288/4885HDAC10 2655/4885HDAC6 1819/4885 |
| US-10808231-B2 | Modified helicases | DDX21, DDX5, DDX17 | HDAC4 2288/4885HDAC10 2655/4885HDAC6 1819/4885 |
| US-20210123032-A1 | MODIFIED HELICASES | DDX21, DDX5, DDX17 | HDAC4 2288/4885HDAC10 2655/4885HDAC6 1819/4885 |
| US-12252717-B2 | Modified helicases | DDX21, DDX5, DDX17 | HDAC4 2288/4885HDAC10 2655/4885HDAC6 1819/4885 |
| US-20080233611-A1 | Orthogonal Translation Components for the in Vivo Incorporation of Unnatural Amino Acids | AARS1, NSUN3, OSGEP | HDAC4 4356/4885HDAC10 3842/4885HDAC6 3240/4885 |
| US-20260028379-A1 | MUTANT PORE | PTMS, NUP50, NUP205 | HDAC4 4675/4885HDAC10 4041/4885HDAC6 4778/4885 |
| US-20230227799-A1 | MODIFIED HELICASES | DDX21, DDX5, DDX17 | HDAC4 2288/4885HDAC10 2655/4885HDAC6 1819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.